Rhumbline Advisers Has $19.84 Million Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Rhumbline Advisers increased its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 2.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 341,854 shares of the company's stock after buying an additional 8,177 shares during the quarter. Rhumbline Advisers owned 0.18% of Doximity worth $19,838,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Global Retirement Partners LLC grew its position in Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after acquiring an additional 440 shares during the last quarter. Larson Financial Group LLC boosted its stake in Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after purchasing an additional 250 shares in the last quarter. Optimum Investment Advisors acquired a new position in Doximity in the fourth quarter worth $43,000. Kapitalo Investimentos Ltda bought a new stake in shares of Doximity during the fourth quarter worth $50,000. Finally, Huntington National Bank increased its stake in shares of Doximity by 1,440.8% in the fourth quarter. Huntington National Bank now owns 1,094 shares of the company's stock valued at $58,000 after buying an additional 1,023 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Insider Buying and Selling at Doximity

In other news, CFO Anna Bryson sold 45,000 shares of the company's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer now directly owns 357,165 shares of the company's stock, valued at approximately $20,440,552.95. This represents a 11.19% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $56.93, for a total value of $113,860.00. Following the transaction, the director now owns 16,618 shares of the company's stock, valued at $946,062.74. The trade was a 10.74% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 51,000 shares of company stock worth $2,900,770 over the last quarter. 37.40% of the stock is currently owned by insiders.

Doximity Price Performance

DOCS stock traded up $0.48 during midday trading on Tuesday, hitting $58.54. The company's stock had a trading volume of 1,627,213 shares, compared to its average volume of 2,134,343. The company's fifty day moving average price is $54.80 and its 200 day moving average price is $58.36. Doximity, Inc. has a twelve month low of $25.00 and a twelve month high of $85.21. The stock has a market capitalization of $10.99 billion, a P/E ratio of 58.54, a PEG ratio of 4.10 and a beta of 1.32.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings results on Thursday, May 15th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. The firm's revenue was up 17.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.25 earnings per share. Equities analysts expect that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DOCS. Needham & Company LLC reduced their price target on shares of Doximity from $82.00 to $67.00 and set a "buy" rating on the stock in a research report on Friday, May 16th. Robert W. Baird reduced their target price on shares of Doximity from $87.00 to $65.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. Mizuho lowered their price target on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a report on Friday, May 16th. Raymond James reduced their price objective on Doximity from $83.00 to $65.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Finally, KeyCorp lowered their target price on Doximity from $83.00 to $70.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Eleven investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Doximity has a consensus rating of "Moderate Buy" and an average target price of $62.84.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.